These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28533835)

  • 1. [Primary colonic extranasal NK/T-cell lymphoma: about a case].
    Fares S; Lamchahab M; Aniba M; Lembarki G; Mousalli N; Regragui M; Karkouri M; Quessar A
    Pan Afr Med J; 2017; 26():112. PubMed ID: 28533835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study.
    Jaccard A; Gachard N; Marin B; Rogez S; Audrain M; Suarez F; Tilly H; Morschhauser F; Thieblemont C; Ysebaert L; Devidas A; Petit B; de Leval L; Gaulard P; Feuillard J; Bordessoule D; Hermine O;
    Blood; 2011 Feb; 117(6):1834-9. PubMed ID: 21123825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extranodal NK/T cell lymphoma, nasal type, presenting with meningeal infiltration in a Caucasian female.
    Hildyard C; Sheikh S; Eyre T; Collins G
    Br J Haematol; 2013 Dec; 163(5):550. PubMed ID: 24033120
    [No Abstract]   [Full Text] [Related]  

  • 4. A phase 2 study of methotrexate, etoposide, dexamethasone, and pegaspargase chemotherapy for newly diagnosed, relapsed, or refractory extranodal natural killer/T-cell lymphoma, nasal type: a multicenter trial in Northwest China.
    Liang R; Gao GX; Chen JP; Wang JS; Wang XM; Zeng Y; Bai QX; Zhang T; Yang L; Dong BX; Gu HT; Shu MM; Hao CX; Wang JH; Zhang N; Chen XQ
    Hematol Oncol; 2017 Dec; 35(4):619-629. PubMed ID: 27723108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of pegaspargase in extra nodal natural killer/T-cell lymphoma nasal type: A case report from China.
    Xiong X; Cai Z; Yang J; Shu X
    J Cancer Res Ther; 2015; 11(3):665. PubMed ID: 26458696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved prognosis of extranodal NK/T cell lymphoma, nasal type of nasal origin but not extranasal origin.
    Yamaguchi M; Suzuki R; Miyazaki K; Amaki J; Takizawa J; Sekiguchi N; Kinoshita S; Tomita N; Wada H; Kobayashi Y; Niitsu N; Ando T; Maeda T; Saito B; Matsuoka H; Sakai R; Kubota N; Masaki Y; Kameoka Y; Asano N; Oguchi M; Katayama N
    Ann Hematol; 2019 Jul; 98(7):1647-1655. PubMed ID: 31001658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ifosfamide, methotrexate, etoposide, and prednisolone (IMEP) plus L-asparaginase as a first-line therapy improves outcomes in stage III/IV NK/T cell-lymphoma, nasal type (NTCL).
    Kim M; Kim TM; Kim KH; Keam B; Lee SH; Kim DW; Lee JS; Jeon YK; Kim CW; Heo DS
    Ann Hematol; 2015 Mar; 94(3):437-44. PubMed ID: 25300500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early radiotherapy has an essential role for improving survival in patients with stage I-II nasal-type of NK/T cell lymphoma treated with L-asparaginase-containing chemotherapy--a single institution experience.
    Zang J; Li C; Luo SQ; Wang JH; Xu M; Zhao LN; Li WW; Yang H; Xiao F; Hitchcock YJ; Shi M
    Ann Hematol; 2015 Apr; 94(4):583-91. PubMed ID: 25409913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment with L-asparaginase-based regimen for primary pulmonary NK/T cell lymphoma: a case report and review of the literature.
    Gui W; Yang B; Shen Q; Bai M; Wang J; Guan T; Zhao J; Wang J; Su L
    Clin Respir J; 2015 Oct; 9(4):493-6. PubMed ID: 24761980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed Diagnosis of a Nasal Type Lymphoma Misdiagnosed as Persistent Sinusitis.
    Celentano A; Mascolo M; Cirillo N; De Rosa G; Mignogna MD
    J Adolesc Young Adult Oncol; 2017 Jun; 6(2):381-384. PubMed ID: 28061034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical management of natural killer/T-cell lymphoma.
    Tse E; Kwong YL
    Curr Opin Oncol; 2012 Sep; 24(5):480-6. PubMed ID: 22691924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of pegaspargase, etoposide, methotrexate and dexamethasone in newly diagnosed advanced-stage extra-nodal natural killer/T-cell lymphoma with the analysis of the prognosis of whole blood EBV-DNA.
    Liang JH; Wang L; Peter Gale R; Wu W; Xia Y; Fan L; Li JY; Xu W
    Blood Cancer J; 2017 Sep; 7(9):e608. PubMed ID: 29016569
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study.
    Yamaguchi M; Kwong YL; Kim WS; Maeda Y; Hashimoto C; Suh C; Izutsu K; Ishida F; Isobe Y; Sueoka E; Suzumiya J; Kodama T; Kimura H; Hyo R; Nakamura S; Oshimi K; Suzuki R
    J Clin Oncol; 2011 Nov; 29(33):4410-6. PubMed ID: 21990393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nasal extranodal peripheral NK/T-cell lymphoma treated by the protocol NK/T-cell high-dose-methotrexate L-asparaginase dexamethasone.
    Bekadja MA; Benredouane H; Audouin J; Mansouri D; Mehadji H; Brahimi M; Arabi A; Osmani S; Entasoltane B
    Hematol Oncol Stem Cell Ther; 2011; 4(1):49-50. PubMed ID: 21460609
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase 2 trial of "sandwich" L-asparaginase, vincristine, and prednisone chemotherapy with radiotherapy in newly diagnosed, stage IE to IIE, nasal type, extranodal natural killer/T-cell lymphoma.
    Jiang M; Zhang H; Jiang Y; Yang Q; Xie L; Liu W; Zhang W; Ji X; Li P; Chen N; Zhao S; Wang F; Zou L
    Cancer; 2012 Jul; 118(13):3294-301. PubMed ID: 22139825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of advanced extranodal NK/T cell lymphoma, nasal-type and aggressive NK-cell leukemia.
    Suzuki R
    Int J Hematol; 2010 Dec; 92(5):697-701. PubMed ID: 21116747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of extranodal natural killer/T-cell lymphoma, nasal type, complicated by severe hemophagocytic syndrome, with dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide chemotherapy followed by autologous stem cell transplant.
    Inoue D; Nagai Y; Takiuchi Y; Nagano S; Arima H; Kimura T; Shimoji S; Mori M; Togami K; Tabata S; Yanagita S; Matsushita A; Nagai K; Maruoka H; Imai Y; Suzuki R; Takahashi T
    Leuk Lymphoma; 2010 Apr; 51(4):720-3. PubMed ID: 20233057
    [No Abstract]   [Full Text] [Related]  

  • 18. Nasal Type Extranodal Natural Killer/T (NK/T) Cell Lymphoma Presenting as Periorbital Cellulitis: A Case Report.
    Al Shawabkeh MA; Al Sulaiti M; Al Sa'ey H; Ganesan S
    Am J Case Rep; 2016 Dec; 17():934-938. PubMed ID: 27932776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent chemoradiotherapy followed by L-asparaginase-containing chemotherapy, VIDL, for localized nasal extranodal NK/T cell lymphoma: CISL08-01 phase II study.
    Kim SJ; Yang DH; Kim JS; Kwak JY; Eom HS; Hong DS; Won JH; Lee JH; Yoon DH; Cho J; Nam TK; Lee SW; Ahn YC; Suh C; Kim WS
    Ann Hematol; 2014 Nov; 93(11):1895-901. PubMed ID: 24947798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and management of natural killer-cell malignancies.
    Ishida F; Kwong YL
    Expert Rev Hematol; 2010 Oct; 3(5):593-602. PubMed ID: 21083476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.